$ATEC

Why is Alphatec Holdings stock surging today?

Alphatec Holdings (ATEC) stock rose 19.1% after CEO Patrick Miles bought 115,000 shares for $1.01M at $8.81 each. The company reported Q2 revenue of $213.5M, up 15% YoY, and reaffirmed FY2026 guidance of $882M. The move coincided with a broader market rebound, with the S&P 500 and Nasdaq gaining 1.0% and 1.1% respectively.

Original reporting
Published Sep 11, 2026, 6:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 6:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ATEC
Bullish
medium confidence
Mentioned
$ATEC
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ATECBullishMed
01

Why it matters

The insider purchase adds a fresh catalyst, amplifying the stock's momentum after a weak prior run.

02

Market read

The news provides a new, material catalyst for ATEC, likely influencing short‑term trading decisions.

03

What to watch

Potential dilution from upcoming financing rounds not discussed.

Relevance 6/10Novelty 6/10Timing: afternoon trading today

Background

Alphatec reported Q2 revenue up 15% YoY and reaffirmed FY2026 guidance of $882M.

Company-level read

Ticker impact

$ATECBullishMedium confidence
Context

CEO Patrick Miles bought 115,000 shares for $1.01M, triggering a 19.1% price surge.

Expected impact

Potential continued rally toward $12‑$13 as short interest eases.

Evidence & confidence

The buy is sizable relative to float and follows a low price, likely attracting momentum traders.

Market effects

Spine‑technology sector may see heightened interest in other low‑float peers.

U.S. small‑cap market could benefit from the short‑squeeze narrative.

Limited to U.S. equity markets; no broader macro effect.

Counterpoint

The buy could be a personal hedge; price may be overbought after the sharp rally.

Key entities

  • Patrick Miles

    CEO of Alphatec Holdings who made the insider purchase.

  • Alphatec Holdings

    Spine technology firm listed on NASDAQ.

Related articles

$ATECMedAI 8/10

Alphatec Q3 Earnings Call Highlights

Alphatec reported Q3 earnings with higher margins (72%) and positive free cash flow ($6M). Full-year 2026 revenue guidance was reduced to $862M due to market softness and supply constraints. The company highlighted growth in EOS and Valence platforms. Alphatec ended the quarter with $135M in liquidity.

$ATECMedAI 8/10

ATEC Reports Third Quarter Financial Results – Ortho Spine News

Alphatec Holdings (ATEC) reported Q3 2026 revenue of $221M, up 13% YoY, with surgical revenue at $202M, up 14%. Adjusted EBITDA was $38M, or 17% of revenue, up 400 bps YoY. Case volumes grew 20% and new surgeon users increased 25%. The company expects full-year 2026 revenue of $862M, adjusted EBITDA of $137M, and $10M in free cash flow.

$ATECMedAI 8/10

Alphatec: Q3 Earnings Snapshot

Alphatec Holdings Inc. (ATEC) reported a Q3 loss of $5.5 million, or 3 cents per share, with adjusted earnings of 9 cents per share. Revenue was $221.2 million, missing estimates of $224.3 million. The company expects full-year revenue of $862 million. ATEC shares have fallen 46% YTD and 31% over the past year.